Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Travoprost vs Timolol in Glaucoma or Ocular Hypertension
NCT00763061Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- May 2006
- Primary completion
- Apr 2008
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of travoprost in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started May 2006; status: completed.
02
Drugs
travoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00763061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00763061.